Sikkerhedsprofilen for lamotrigin hos børn i alderen 1 måned til 2 år var omtrent den samme som hos ældre børn, bortset fra at der oftere blev rapporteret om en klinisk signifikant forværring af anfaldene (> = 50%) hos børn under 2 år (26%) sammenlignet med ældre børn (14%).
The safety profile of lamotrigine in children aged 1 month to 2 years was similar to that in older children except that clinically significant worsening of seizures (> =50%) was reported more often in children under 2 years of age (26%) as compared to older children (14%).